RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.

Arnab Chakravarti; Meihua Wang; H. Ian Robins; Tim Lautenschlaeger; Walter J. Curran; David G. Brachman; Christopher J. Schultz; Ali Choucair; Marisa Dolled-Filhart; Jason Christiansen; Mark Gustavson; Annette Molinaro; Paul Mischel; Adam P. Dicker; Markus Bredel; Minesh Mehta

doi:10.1016/j.ijrobp.2012.10.008

RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.

Arnab Chakravarti
, Meihua Wang
, H. Ian Robins
, Tim Lautenschlaeger
, Walter J. Curran
, David G. Brachman
, Christopher J. Schultz
, Ali Choucair
, Marisa Dolled-Filhart
, Jason Christiansen
, Mark Gustavson
, Annette Molinaro
, Paul Mischel
, Adam P. Dicker
, Markus Bredel
, Minesh Mehta

Herbert Wertheim Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	International Journal of Radiation Oncology Biology Physics
Volume	85
DOIs	https://doi.org/10.1016/j.ijrobp.2012.10.008
State	Published - Jan 4 2013

Disciplines

Medicine and Health Sciences
Medical Biophysics

Access to Document

10.1016/j.ijrobp.2012.10.008License: Unspecified

Cite this

Chakravarti, A., Wang, M., Robins, H. I., Lautenschlaeger, T., Curran, W. J., Brachman, D. G., Schultz, C. J., Choucair, A., Dolled-Filhart, M., Christiansen, J., Gustavson, M., Molinaro, A., Mischel, P., Dicker, A. P., Bredel, M., & Mehta, M. (2013). RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients. International Journal of Radiation Oncology Biology Physics, 85. https://doi.org/10.1016/j.ijrobp.2012.10.008

Chakravarti, A, Wang, M, Robins, HI, Lautenschlaeger, T, Curran, WJ, Brachman, DG, Schultz, CJ, Choucair, A, Dolled-Filhart, M, Christiansen, J, Gustavson, M, Molinaro, A, Mischel, P, Dicker, AP, Bredel, M & Mehta, M 2013, 'RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.', International Journal of Radiation Oncology Biology Physics, vol. 85. https://doi.org/10.1016/j.ijrobp.2012.10.008

@article{9bf744388d5b4cfaa88b8df32a932490,

title = "RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.",

author = "Arnab Chakravarti and Meihua Wang and Robins, \{H. Ian\} and Tim Lautenschlaeger and Curran, \{Walter J.\} and Brachman, \{David G.\} and Schultz, \{Christopher J.\} and Ali Choucair and Marisa Dolled-Filhart and Jason Christiansen and Mark Gustavson and Annette Molinaro and Paul Mischel and Dicker, \{Adam P.\} and Markus Bredel and Minesh Mehta",

year = "2013",

month = jan,

day = "4",

doi = "10.1016/j.ijrobp.2012.10.008",

language = "American English",

volume = "85",

journal = "International Journal of Radiation Oncology Biology Physics",

}

TY - JOUR

T1 - RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.

AU - Chakravarti, Arnab

AU - Wang, Meihua

AU - Robins, H. Ian

AU - Lautenschlaeger, Tim

AU - Curran, Walter J.

AU - Brachman, David G.

AU - Schultz, Christopher J.

AU - Choucair, Ali

AU - Dolled-Filhart, Marisa

AU - Christiansen, Jason

AU - Gustavson, Mark

AU - Molinaro, Annette

AU - Mischel, Paul

AU - Dicker, Adam P.

AU - Bredel, Markus

AU - Mehta, Minesh

PY - 2013/1/4

Y1 - 2013/1/4

UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199329/

U2 - 10.1016/j.ijrobp.2012.10.008

DO - 10.1016/j.ijrobp.2012.10.008

M3 - Article

VL - 85

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

ER -

RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.

Disciplines

Access to Document

Other files and links

Cite this